iSpecimen Inc., a biospecimen procurement company, announced plans to create a $200 million digital asset reserve centered on Solana's native token, SOL. The company aims to diversify its assets and support business growth by investing in tokenized real-world assets and highly rated cryptocurrencies. iSpecimen will employ a professional reserve management team to oversee policy development, counterparty screening, and risk management. The reserve will acquire SOL through over-the-counter transactions, including locked tokens with transfer restrictions. iSpecimen plans to fund the reserve through regular financing and adopt a long-term strategy of buying at a discount. The company will stake a portion of its SOL holdings for interest while retaining some for spot trading.